Sally Beauty Q4 EPS Jumps 22%, FY27 Guidance Set at $2.20-$2.30

Sally Beauty Holdings (NYSE: SBH) reported fiscal 2026 fourth quarter and full year results on 10 November 2026, posting fourth quarter consolidated net sales of $953 million, up 0.6%, GAAP diluted EPS of $0.60, up 22%, and adjusted diluted EPS of $0.62, up 13%. Consolidated comparable sales grew 0.9% and GAAP operating earnings reached $92 million at a 9.7% margin. The company guided fiscal 2027 adjusted diluted EPS to $2.20-$2.30 on net sales of $3.77-$3.81 billion.

Context — Why Sally Beauty's Q4 Margin Story Matters Now

The fourth quarter marked a reversal from the full-year pattern. Full year GAAP operating earnings of $326 million represented a 0.4% decline, and GAAP operating margin contracted 20 basis points to 8.7%. The quarter alone delivered 130 basis points of GAAP operating margin expansion to 9.7%, a swing the company attributed to lower adjusted selling, general and administrative expenses, which fell $5 million year over year to $400 million.

That expense discipline is the mechanism behind the earnings use. Net sales grew less than one percent, yet GAAP net earnings rose 15.6% to $57.7 million and GAAP diluted EPS climbed 22.4%. Adjusted operating earnings of $95 million produced a 10.0% margin, up 60 basis points.

The company framed the quarter as the close of a year spent on "disciplined execution, new customer growth, digital and omnichannel expansion, product innovation," in the words of chief executive Denise Paulonis. She said the company generated $323 million of cash from operations, strengthened its balance sheet and returned capital to shareholders.

Macro conditions were not a tailwind. Consolidated gross margin slipped 30 basis points to 51.9% in the quarter, which the company attributed to cost of products sold rising 1.1% against 0.6% sales growth. The full year told the opposite story on gross margin, which expanded 40 basis points to 52.0% GAAP and 52.1% adjusted.

The trigger for the quarter's earnings beat was cost control rather than demand acceleration. Comparable sales growth of 0.9% is modest, and the two segments diverged sharply, a split that shapes how the FY27 guide should be read.

Data — Sally Beauty's Segment Split and Balance Sheet

Sally Beauty Supply, the larger segment, generated fourth quarter net sales of $550.3 million, up 1.6%, with comparable sales growth of 2.0% and segment operating earnings of $88.4 million, up 2.6%, at a 16.1% operating margin.

Beauty Systems Group moved the other way. Net sales fell 0.8% to $402.2 million, comparable sales declined 0.6%, and segment operating earnings rose 1.2% to $51.9 million at a 12.9% margin. BSG gross margin held flat at 40.0%.

Metric	Q4 FY26	Q4 FY25	Change
Consolidated net sales	$952.5M	$947.1M	+0.6%
GAAP diluted EPS	$0.60	$0.49	+22.4%
Adjusted diluted EPS	$0.62	$0.55	+13%
GAAP operating margin	9.7%	8.4%	+130 bps

Digital is the fastest-growing channel. Global e-commerce sales rose 8% in the quarter to $113 million, or 12% of net sales, and 10% for the full year to $441 million, also 12% of net sales.

On the balance sheet, cash and equivalents stood at $158 million with no outstanding borrowings under the asset-based revolver. Inventory of $1.00 billion was up 1% year over year, roughly matching the 0.9% full-year sales increase. Long-term debt fell to $784 million from $862 million, and the company ended the quarter at 1.4x net debt use.

Analysis — What Sally Beauty's Guidance Implies for SBH

Fiscal 2027 guidance of $2.20-$2.30 adjusted diluted EPS sits against the $2.08 just reported, implying growth in the high single digits to low double digits. The midpoint of $2.25 would extend the algorithm the company described rather than accelerate it.

The comparable sales target of 1% to 2% is the crux. Fiscal 2026 delivered 0.5% consolidated comparable growth, and the fourth quarter's 0.9% still trailed the 1% floor of the new guide. Hitting the low end requires only modest improvement; the high end requires BSG comparable sales to turn positive after a 0.6% fourth quarter decline.

Capital allocation is a second lever. The company repurchased $113 million of stock in fiscal 2026, including 2.6 million shares for $42 million in the fourth quarter, and repaid $80 million of term loan debt. Guidance assumes 50% of free cash flow goes to share repurchases, which mechanically supports per-share earnings when net income is flat.

The counter-argument is that gross margin compression in the quarter could persist if product cost inflation outpaces pricing. The company did not disclose its pricing plans or promotional cadence for fiscal 2027, and it did not break out the fuel for growth initiative costs that its adjusted figures exclude.

Positioning reflects a low-growth, cash-generative retailer. Buybacks and debt reduction draw income-oriented holders, while the modest top-line trajectory limits multiple expansion. The stock's reaction depends on whether investors credit the margin trajectory or discount the sales line.

Outlook — What to Watch in Sally Beauty's FY27

The first fiscal quarter guide calls for net sales of $945-$955 million, comparable sales growth of 0.5% to 1.5%, adjusted operating earnings of $75-$80 million and adjusted diluted EPS of $0.48-$0.52. The company assumes roughly 30 basis points of unfavorable foreign currency impact in that quarter.

Full year capital expenditures are guided to approximately $140 million, with free cash flow of approximately $200 million against the $210 million generated in fiscal 2026. The company defines free cash flow as GAAP operating cash flow less capital expenditure payments.

Investors should track the BSG comparable sales line, since that segment's -0.6% print is the gap between the current run rate and the guidance floor. Gross margin is the second variable, given the 30 basis point fourth quarter decline.

The company did not provide a reconciliation for forward-looking non-GAAP measures, citing the difficulty of forecasting items outside its control. That limits how precisely the guide can be benchmarked against GAAP results.

Frequently Asked Questions

What does Sally Beauty's FY27 guidance mean for retail investors?

The guide of $2.20-$2.30 adjusted diluted EPS compares with $2.08 in fiscal 2026, so the company is projecting growth rather than a reset. It also assumes half of free cash flow funds buybacks, which lifts per-share results even if net income is flat. The 1% to 2% comparable sales target is the assumption that carries the most execution risk.

Why did Sally Beauty's fourth quarter EPS grow faster than sales?

Sales rose 0.6% while GAAP diluted EPS rose 22.4%. The gap came from adjusted selling, general and administrative expenses falling $5 million to $400 million, plus a lower share count after buybacks and a 7.2% decline in interest expense to $13.9 million. Operating use on a nearly flat revenue base drove the result.

How did the two Sally Beauty segments perform differently?

Sally Beauty Supply grew net sales 1.6% to $550.3 million with 2.0% comparable sales growth and a 16.1% operating margin. Beauty Systems Group declined 0.8% to $402.2 million with comparable sales down 0.6%, though its operating earnings rose 1.2% to $51.9 million. The divergence is the central question for the fiscal 2027 comparable sales target.

Bottom Line

Sally Beauty's cost control drove a strong fourth quarter, but fiscal 2027 hinges on reversing Beauty Systems Group's sales decline.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.